ArticlePediatrics2026
Tuberculosis Disease and Infection in US-Bound International Adoptees: 2016 to 2023.
Article in Pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThe objective of this study was to evaluate required culture-based overseas tuberculosis (TB) screening in US-bound international adoptees.
methodsWe conducted a cross-sectional analysis of 22 053 international adoptees who underwent TB screening overseas and arrived in the United States during 2016 to 2023.
resultsOf 22 053 international adoptees (aged younger than 18 years) screened for TB overseas, 12 (54 cases/100 000 persons) were diagnosed with TB disease, and 169 (766 cases/100 000 persons) had suspected TB disease (defined for this analysis as a chest radiograph or clinical signs/symptoms suggestive of TB or known HIV infection but negative sputum culture results overseas). Of 15 386 persons who underwent a tuberculin skin test (TST) or interferon-γ release assay (IGRA) overseas, 390 (2.5%) were diagnosed with latent TB infection (LTBI). Among 12 persons who initiated treatment of TB disease overseas, 10 (83.3%) completed post-arrival evaluation in the United States; of these, none were diagnosed with TB disease after arrival. Among 169 persons diagnosed overseas with suspected TB disease, 108 (63.9%) completed post-arrival evaluation; of these, 2 (1.9%) were diagnosed with TB disease. Among 390 persons diagnosed overseas with LTBI, 220 (56.4%) completed post-arrival evaluation; of these, none were diagnosed with TB disease. Of 150 persons diagnosed with LTBI at post-arrival evaluation, 137 (91.3%) were recommended for treatment; of these, 104 (75.9%) initiated and 79 (57.7%) completed treatment.
conclusionsUS-bound international adoptees have a similarly high prevalence of TB disease compared with US-bound immigrant and refugee children, highlighting the importance of TB screening before immigration and ensuring timely recommended post-arrival evaluation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.